Implementation of updates to ISO 14644 Parts 1 & 2 (2015)
Information for manufacturers of sterile therapeutic goods
Published
Related content
- TGA expectations for overseas manufacturing sites hosting remote inspections during the COVID-19 pandemicInformation to assist overseas manufactures who may undergo a remote Good Manufacturing Practice inspection during the COVID-19 pandemic
- GMP approach to overseas manufacturers of medicines and biologicals during the COVID-19 pandemicUpdate to GMP approach to overseas manufacturers of medicines and biologicals during the COVID-19 pandemic.
- Exemption to enable timely access to radiopharmaceuticals and RAIInformation on an exemption for radiopharmaceuticals that facilitates interstate supply during COVID-19